Fortress Biotech Inc - 9.375% PRF PERPETUAL USD 25 - Ser A
FBIOP
Get informed when a big investor buys or sells
+ FollowMarket Cap$146.11M
Close$
$-3.14
116.7% downside
Current Fair Value
116.7% downsideOvervalued by 116.7% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $146.11 Million |
|---|---|
| Enterprise Value | $-50,686,929.00 |
| Dividend Yield | $2.34 (-) |
| Earnings per Share | $-0.07 |
| Beta | 1.21 |
| Outstanding Shares | 31,540,595 |
Return
| Return on Equity | 74.61% |
|---|---|
| Return on Assets | 33.91% |
| Return on Invested Capital | -11.34% |
Valuation & Multiples
| P/E Ratio | 0.86 |
|---|---|
| PEG | -0.08 |
| Price to Sales | 9.38 |
| Price to Book Ratio | 3.13 |
| Enterprise Value to Revenue | -0.77 |
| Enterprise Value to EBIT | 1.76 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | -1.16 |
| Debt to Equity | 0.36 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
May 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
August 17, 2026
EPS Estimate
$-0.20
Average shareholder expectationRevenue Estimate
$18.30 M
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Fortress Biotech Inc
111 employees
CEO: Lindsay Rosenwald